OAC Newsroom

More than 100 million adults in America are living with obesity, yet only 1% of providers are trained in obesity medicine, leaving many patients to turn to non-expert sources for medical information and prescriptions The Obesity Medicine Scholarship program, funded by Found, bridges the gap in care and encourages physicians to become American Board of
Read Article

The Obesity Action Coalition (OAC) is pleased to share that Found has renewed its support for the OAC’s Chairman’s Council at the Patron level. Thank you, Found,  for continuing to support and champion the OAC’s mission. About Found Found is an evidence-based weight care solution that combines the best of modern medicine with access to
Read Article

The OAC is pleased to share that Medtronic, a long-time supporter of OAC, has renewed its support of the organization on OAC’s Chairman’s Council at the Silver level.  Thank you, Medtronic, for continuing to support and champion our mission! About Medtronic Medtronic is a global leader in medical technology and one of the largest medical device
Read Article

The OAC is pleased to share that Procare Health, a long-time supporter of OAC, has renewed its support of the organization on OAC’s Chairman’s Council at the Patron level. Thank you, ProCare Health, for continuing to support and champion our mission! More about ProCare Health As a leader in innovative health products, ProCare Health produced
Read Article

The Obesity Action Coalition (OAC) is pleased to share that seca Medical Body Composition has joined OAC’s Chairman’s Council at the Patron level! Thank you for committing to support and champion the OAC’s mission. About seca Medical Body Composition Numbers like weight and BMI only scratch the surface of your story. Just as treatments have
Read Article

  The Obesity Society, Obesity Action Coalition and Obesity Medicine Association have issued a joint statement recommending that patients do not use available compounded alternatives to GLP-1 medications. Even though medications like Wegovy (semaglutide) and Zepbound (tirzepatide) demonstrate remarkable effectiveness, frustration exists on accessing such Food and Drug Administration (FDA)-approved treatments due to medication shortages,
Read Article

  The Obesity Action Coalition is thrilled to introduce a BRAND-NEW event series – Your Weight Matters Regional, a FREE weight and health event coming to cities across the United States!  At Your Weight Matters Regional, you will explore a wide range of topics, including:  Weight management strategies Nutrition Mental health And much more! Our
Read Article

The OAC is honored to welcome three new members to the OAC National Board of Directors. Jason Krynicki, Michele Tedder and Linda Shapiro Manning, MD, PhD, bring their personal experience and dedication to improving the lives of people living with obesity and join the Board in directing the OAC and its activities, setting long-term goals
Read Article

The Obesity Action Coalition (OAC) is pleased to share that Bariatric Advantage has joined OAC’s Chairman’s Council at the Patron level! Thank you for committing to support and champion the OAC’s mission. About Bariatric Advantage Bariatric Advantage nutritional supplements and products are scientifically formulated to meet the specialized nutritional demands of patients who have undergone
Read Article

Washington, DC – Today, members of the Obesity Action Coalition (OAC) will gather on Capitol Hill to meet with various legislators to express the importance of expanding access to obesity care and urge legislators to co-sponsor the Treat and Reduce Obesity Act (TROA). TROA is a bipartisan bill that will give Medicare-eligible Americans greater access
Read Article

TAMPA, Fla., Nov. 28, 2023 — The Obesity Action Coalition (OAC) announces the publication of a “Joint Statement in Support of Closing Gaps in the Drug Approval Process and Drug Labeling for People with Obesity.” The statement is co-signed by the OAC, The Obesity Society, the Stop Obesity Alliance, the Obesity Medicine Association, and the
Read Article

  On behalf of the American Society for Metabolic and Bariatric Surgery, the Obesity Action Coalition (OAC), the Obesity Medicine Association, the STOP Obesity Alliance, and The Obesity Society (TOS), we call on the FDA to close gaps in the testing and approval process for new drugs intended for use by people with obesity. Currently,
Read Article